131 related articles for article (PubMed ID: 23299272)
1. Effect of amelogenin ECM protein on the healing of chronic leg ulcers with atrophie blanche.
Fogh K; Nielsen CB; Dam W
J Wound Care; 2012 Dec; 21(12):612-4. PubMed ID: 23299272
[TBL] [Abstract][Full Text] [Related]
2. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers.
Vowden P; Romanelli M; Price P
J Wound Care; 2007 May; 16(5):189-95. PubMed ID: 17552400
[TBL] [Abstract][Full Text] [Related]
3. New insights into therapy by mathematical analysis: recalcitrant granulated improved more than sclerotic venous leg ulcers with amelogenin treatment.
Renner R; Simon JC
J Dermatol Sci; 2012 Jul; 67(1):15-9. PubMed ID: 22608215
[TBL] [Abstract][Full Text] [Related]
4. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.
Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H
Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801
[TBL] [Abstract][Full Text] [Related]
5. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
[TBL] [Abstract][Full Text] [Related]
6. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
[TBL] [Abstract][Full Text] [Related]
7. Punch grafting for the treatment of ulcerated atrophie blanche.
Orbea Sopeña A; Conde Montero E
Phlebology; 2023 Dec; 38(10):695-697. PubMed ID: 37624370
[No Abstract] [Full Text] [Related]
8. Effect of amelogenin extracellular matrix protein and compression on hard-to-heal venous leg ulcers: follow-up data.
Romanelli M; Kaha E; Stege H; Wnorowski JW; Vowden P; Majamaa H; Lazaro JL
J Wound Care; 2008 Jan; 17(1):17-8, 20-3. PubMed ID: 18210952
[TBL] [Abstract][Full Text] [Related]
9. A trial to assess the efficacy and tolerability of Hyalofill-F in non-healing venous leg ulcers.
Colletta V; Dioguardi D; Di Lonardo A; Maggio G; Torasso F
J Wound Care; 2003 Oct; 12(9):357-60. PubMed ID: 14601230
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche.
Mimouni D; Ng PP; Rencic A; Nikolskaia OV; Bernstein BD; Nousari HC
Br J Dermatol; 2003 Apr; 148(4):789-94. PubMed ID: 12752140
[TBL] [Abstract][Full Text] [Related]
11. Initial rate of healing predicts complete healing of venous ulcers.
Tallman P; Muscare E; Carson P; Eaglstein WH; Falanga V
Arch Dermatol; 1997 Oct; 133(10):1231-4. PubMed ID: 9382561
[TBL] [Abstract][Full Text] [Related]
12. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
[TBL] [Abstract][Full Text] [Related]
13. Immunofluorescence studies of atrophie blanche with antibodies against fibrinogen, fibrin, plasminogen activator inhibitor, factor VIII-related antigen, and collagen type IV.
Brakman M; Faber WR; Kerckhaert JA; Kraaijenhagen RJ; Hart HC
Vasa; 1992; 21(2):143-8. PubMed ID: 1621431
[TBL] [Abstract][Full Text] [Related]
14. Impact of protein deficiency on venous ulcer healing.
Legendre C; Debure C; Meaume S; Lok C; Golmard JL; Senet P
J Vasc Surg; 2008 Sep; 48(3):688-93. PubMed ID: 18579333
[TBL] [Abstract][Full Text] [Related]
15. Postthrombotic or non-postthrombotic severe venous insufficiency: impact of removal of superficial venous reflux with or without subcutaneous fasciotomy.
Christenson JT
J Vasc Surg; 2007 Aug; 46(2):316-21. PubMed ID: 17664106
[TBL] [Abstract][Full Text] [Related]
16. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
17. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: experimental and clinical evidence.
Romanelli M; Dini V; Vowden P; Agren MS
Clin Interv Aging; 2008; 3(2):263-72. PubMed ID: 18686749
[TBL] [Abstract][Full Text] [Related]
18. Calf muscle pump impairment and delayed healing of venous leg ulcers: air plethysmographic findings.
Simka M
J Dermatol; 2007 Aug; 34(8):537-44. PubMed ID: 17683384
[TBL] [Abstract][Full Text] [Related]
19. Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements.
Belcaro G; Cesarone MR; Errichi BM; Di Renzo A; Errichi S; Ricci A; Gizzi G; Dugall M; Cacchio M; Ruffini I; Fano F; Vinciguerra G; Grossi MG
Angiology; 2007; 58(3):323-8. PubMed ID: 17626987
[TBL] [Abstract][Full Text] [Related]
20. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a 6-month follow-up.
Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Zhang Y; Dickerson JE; Slade HB
Wound Repair Regen; 2013; 21(5):682-7. PubMed ID: 23927847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
